A single intravenous dose of dimethyltryptamine, the psychoactive compound found in the Amazonian brew ayahuasca, produced significant and lasting reductions in depression symptoms across a ...
Researchers found that a single 21.5mg dose of DMT reduced depression symptoms compared to placebo in patients with treatment ...
People with major depressive disorder saw significant and lasting reductions in their symptoms from a single dose of the psychedelic compound DMT in a ...
In 2017, the World Health Organization (WHO) identified major depressive disorder as the leading cause of disability ...
One dose of the active compound in ayahuasca significantly improves depressive symptoms in early stages of a clinical trial, according to a new study.View on euronews ...
From mood trackers to guided cognitive-behavioral therapy (CBT) and peer support, depression apps are crowding the digital marketplace. As more patients turn to this technology to ease their symptoms, ...
A Phase IIa clinical trial finds that a single, brief dose of DMT (from ayahuasca) provides rapid and lasting relief for depression.